Overview
Common arterial trunk (also known as truncus arteriosus or persistent truncus arteriosus) is a rare congenital heart defect in which a single large blood vessel (the truncus) arises from the heart instead of the normal two separate vessels (the aorta and the pulmonary artery). During normal fetal development, the truncus arteriosus divides into these two great arteries; in this condition, that separation fails to occur. The single trunk overrides a ventricular septal defect (VSD), receiving blood from both the right and left ventricles, resulting in mixing of oxygen-rich and oxygen-poor blood that is then distributed to the body, lungs, and coronary arteries. Infants with common arterial trunk typically present in the neonatal period with signs of congestive heart failure, cyanosis (bluish discoloration of the skin due to low oxygen levels), tachypnea (rapid breathing), poor feeding, failure to thrive, and excessive pulmonary blood flow. A single semilunar (truncal) valve may be abnormal, with regurgitation or stenosis. Without treatment, the condition carries a very high mortality rate in the first year of life due to heart failure and progressive pulmonary vascular disease (Eisenmenger syndrome). The condition is classified into several types (most commonly using the Van Praagh or Collett-Edwards classification) based on the origin of the pulmonary arteries from the trunk. Treatment is surgical and is typically performed in the neonatal period. The primary repair involves separating the pulmonary arteries from the truncal vessel, closing the VSD to direct left ventricular outflow into the reconstructed aorta, and establishing right ventricle-to-pulmonary artery continuity using a conduit (often a homograft). Patients require lifelong cardiac follow-up, as conduit replacement surgeries are commonly needed as the child grows. Common arterial trunk may occur as an isolated defect or in association with genetic conditions, most notably 22q11.2 deletion syndrome (DiGeorge syndrome), which is found in a significant proportion of affected individuals. Other associated anomalies may include interrupted aortic arch, coronary artery anomalies, and truncal valve abnormalities.
Also known as:
Clinical phenotype terms— hover any for plain English:
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
FDA & Trial Timeline
10 eventsOndokuz Mayıs University
Aarhus University Hospital
Regeneron Pharmaceuticals — PHASE3
Brigham and Women's Hospital — PHASE4
National Institute of Allergy and Infectious Diseases (NIAID) — EARLY_PHASE1
Regeneron Pharmaceuticals — PHASE3
University Hospital of Split — NA
Genoss Co., Ltd.
Dentsply Sirona Implants and Consumables — NA
Istanbul University - Cerrahpasa — NA
Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
Treatments
No FDA-approved treatments are currently listed for Common arterial trunk.
2 clinical trialsare actively recruiting — trials can provide access to cutting-edge therapies.
View clinical trials →Rare Disease Specialist
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Common arterial trunk.
Community
No community posts yet. Be the first to share your experience with Common arterial trunk.
Start the conversation →Latest news about Common arterial trunk
Disease timeline:
New recruiting trial: The NutriNet-Santé Study
A new clinical trial is recruiting patients for Common arterial trunk
New recruiting trial: Pacemaker Implantation Versus Cardioneuroablation for Functional Atrioventricular Block
A new clinical trial is recruiting patients for Common arterial trunk
New recruiting trial: Impact of Pet Cats on Nasal and Gut Microbiota in Patients With Cat Allergen Allergy
A new clinical trial is recruiting patients for Common arterial trunk
New recruiting trial: A Multi-center Registry Study: The Follow-up the Complications for Trans-vaginal Mesh Surgery
A new clinical trial is recruiting patients for Common arterial trunk
New recruiting trial: Study on Neuropsychiatric Behavior in Cadmium-exposed People
A new clinical trial is recruiting patients for Common arterial trunk
New recruiting trial: Tumor-directed Radiation Therapy for Patients With the Highest Risk Category of Localized Prostate Cancer
A new clinical trial is recruiting patients for Common arterial trunk
New recruiting trial: CAT BITE Antibiotic Prophylaxis for the Hand/Forearm (CATBITE)
A new clinical trial is recruiting patients for Common arterial trunk
New recruiting trial: Viral Mucosal Reprogramming
A new clinical trial is recruiting patients for Common arterial trunk
New recruiting trial: Effectiveness of CAT-GSH for Returning Patients
A new clinical trial is recruiting patients for Common arterial trunk
New recruiting trial: Sedentarism of Stroke Survivors in the Valencian Community and Development of a Self-management Program
A new clinical trial is recruiting patients for Common arterial trunk
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Common arterial trunk
What is Common arterial trunk?
Common arterial trunk (also known as truncus arteriosus or persistent truncus arteriosus) is a rare congenital heart defect in which a single large blood vessel (the truncus) arises from the heart instead of the normal two separate vessels (the aorta and the pulmonary artery). During normal fetal development, the truncus arteriosus divides into these two great arteries; in this condition, that separation fails to occur. The single trunk overrides a ventricular septal defect (VSD), receiving blood from both the right and left ventricles, resulting in mixing of oxygen-rich and oxygen-poor blood
At what age does Common arterial trunk typically begin?
Typical onset of Common arterial trunk is neonatal. Age of onset can vary across affected individuals.
Are there clinical trials for Common arterial trunk?
Yes — 2 recruiting clinical trials are currently listed for Common arterial trunk on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.
Which specialists treat Common arterial trunk?
17 specialists and care centers treating Common arterial trunk are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.